GLB1 and galactosialidosis: CTSA protects both GLB1 and NEU1 from lysosomal degradation and activates NEU1 (24), whereas LMC dissociation evoked by CTSA mutations leads to degradation of both NEU1 and GLB1 (25) and causes, in humans, the neurological LSD galactosialidosis.